Childhood bullous pemphigoid: Clinical and immunological findings in a series of 4 cases

Archives of Dermatology

Volumn 143, Issue 2, 2007, Pages 215-220

  Pablo, Maria Isabel Martinez De ^a   González Enseñat, Maria Antonia ^b   Vicente, Asunción ^b   Gilaberte, Montserrat ^c   Mascaró Jr , José Manuel ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL SANT JOAN DE DÉU   (Spain)

^c HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; BULLOUS PEMPHIGOID ANTIGEN 180; COMPLEMENT COMPONENT C3; DAPSONE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; PREDNISOLONE DERIVATIVE; PREDNISOLONE STEAGLATE; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIGEN DETECTION; ARTICLE; BULLOUS PEMPHIGOID; BULLOUS SKIN DISEASE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CHILDHOOD DISEASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOLOGY; INFANT; MALE; PRIORITY JOURNAL; PROTEIN DOMAIN; REMISSION; SKIN BIOPSY; TREATMENT OUTCOME;

AUTOANTIBODIES; COMPLEMENT C3; HUMANS; INFANT; MALE; PEMPHIGOID, BULLOUS;

EID: 33847167589     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.2.215     Document Type: Article

References (24)

1. Rico MJ. Autoimmune blistering disease in children. Semin Dermatol. 1995;14:54-59.
2. Nemeth AJ, Klein AD, Gould EW, Schachner LA. Childhood bullous pemphigoid: clinical and immunologic features, treatment and prognosis. Arch Dermatol. 1991;127:378-386.
3. Chimanovitch I, Hamm H, Georgi M, et al. Bullous pemphigoid of childhood: autoantibodies target the same epitopes within the NC16A domain of BP180 as autoantibodies in bullous pemphigoid of adulthood. Arch Dermatol. 2000;136:527-532.
4. Giudice GJ, Emery DJ, Zelickson BD, Anhalt GJ, Lin Z, Diaz LA. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common noncollagenous site on the BP180 ectodomain. J Immunol. 1993;151:5742-5750.
5. Zillikens D, Mascaró JM, Rose PA, et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies associated with bullous pemphigoid. J Invest Dermatol. 1997;109:679-683.
6. Lever WF. Pemphigus. Medicine. 1953;32:1-123.
7. Kim R, Winkelmann RK. Dermatitis herpetiformis in children: relationship to bullous pemphigoid. Arch Dermatol. 1961;83:895-902.
8. Petronius D, Bergman R. Bullous pemphigoid in two infants. Pediatr Dermatol. 2002;19:119-121.
9. Arechalde A, Braun RP, Calza AM, et al. Childhood bullous pemphigoid associated with IgA antibodies against BP180 or BP230 antigens. Br J Dermatol. 1999;140:112-118.
10. Fox BJ, Odom RB, Findlay RF. Erythromycin therapy in bullous pemphigoid: possible anti-inflammatory effects. J Am Acad Dermatol. 1982;7:504-510.
11. Trüeb RM, Didierjean L, Fellas A, Elias A, Borradori L. Childhood bullous pemphigoid: report of a case with characterization of the targeted antigens. J Am Acad Dermatol. 1999;40:338-344.
12. Gammon WR, Briggaman RA, Inman AO, Queen LL, Wheeler CD Jr. Differentiating anti-lamina lucida and anti-sub-lamina densa anti-BMZ antibodies by direct immunofluorescence on 1.0 sodium chloride-separated skin. J Invest Dermatol. 1984;82:139-144.
13. Tani M, Tani M, Komura A, Murata Y. Bullous pemphigoid of childhood: report of a case and immunoelectron microscopic studies. J Am Acad Dermatol. 1988;19:366-367.
14. Tani M, Shimiza R, Ban M, Murata Y, Tamaki A. Systemic lupus erythematosus with vesiculobullous lesions: immunoelectron microscopic studies. Arch Dermatol. 1984;120:1497-1501.
15. Kirtschig G, Wojnarowska F, Marsden RA, Edwards S, Bhogal B, Black MM. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M Na CL split skin and immunoblotting. Br J Dermatol. 1994;130:610-616.
16. Farrell AM, Kirtschig G, Dalziel KL, et al. Childhood vulval pemphigoid: a clinical and immunopathological study of five patients. Br J Dermatol. 1999;140:308-312.
17. Chan YC, Sun YJ, Ng PPL, Tan SH. Comparison of immunofluorescence microscopy, immunoblotting and enzyme-linked immunosorbent assay methods in the laboratory diagnosis of bullous pemphigoid. Clin Exp Dermatol. 2003;28:651-656.
18. 2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol. 2002;119:1065-1073.
19. Schmidt E, Obe K, Bröcker EB, Zillikens D. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol. 2000;136:174-178.
20. Kromminga A, Scheckenbach C, Georgi M, et al. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180. J Autoimmun. 2000;15:293-300.
21. Downs AM, Lear JT, Bower CP, Kennedy CT. Does influenza vaccination induce bullous pemphigoid? a report of four cases. Br J Dermatol. 1998;138:363.
22. Baykal C, Okan G, Sarica R. Childhood bullous pemphigoid developed after the first vaccination. J Am Acad Dermatol. 2001;44:348-350.
23. Erbagci Z. Childhood bullous pemphigoid following hepatitis B immunization. J Dermatol. 2002;29:781-785.
24. Vanderlugt CL, Begolka WS, Neville KL, et al. The functional significance of epitope spreading and its regulation by co-stimulatory molecules. Immunol Rev. 1998;164:63-72.